Health ❯ Pharmaceuticals

Drug Manufacturing

Quality Assurance Active Pharmaceutical Ingredients Research and Development Supply Chain Management Quality Control Domestic Production Generic Drugs Regulations National Security Branded Drugs

Three Multinationals Paid 46% of Ireland’s 2024 Corporation Tax, Watchdog Says

The fiscal watchdog warns that this reliance heightens budget volatility despite a 15% minimum tax due from 2026.

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

India Notifies Risk-Based Overhaul of Drug R&D Rules

White House Secures Nine More Drugmaker Pacts on MFN Pricing as TrumpRx Nears Launch

AstraZeneca Breaks Ground on $4.5 Billion Virginia Plant With Expanded Cancer and Obesity Drug Production

Spain Approves Hospital-Only Framework for Medical Cannabis Prescriptions

AstraZeneca Pauses £200 Million Expansion of Cambridge Research Site

India Unveils BioE3 Plan for 16 Biomanufacturing Hubs to Cut Import Reliance

J&J Commits $2 Billion to 10-Year Fujifilm Deal for North Carolina Biologics Hub

JAMA Study Finds Most U.S. Drug Plants Located in Disaster-Hit Areas, Exposing Supply Risks

Trump Administration’s Pharma Tariff Decision Remains Weeks Away

FDA Launches PreCheck to Accelerate Domestic Drug Plants

FDA Launches PreCheck to Accelerate U.S. Drug Manufacturing Approvals

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030

AstraZeneca Announces $50 Billion U.S. Manufacturing and R&D Expansion

Karnataka Bans 15 Substandard Drugs and Cosmetics

Engineered E. Coli Converts Plastic Waste to Paracetamol

Amine-Functionalized Graphene Oxide Reactor Enables Ultrafast Beta-Blocker Production

Sanofi Announces $20 Billion U.S. Investment to Expand Manufacturing and R&D

FDA Recalls Duloxetine Over Cancer-Causing Chemical Concerns